Schering Stiftung

Prize winner 

Dr. Sarah Kim-Hellmuth

Dr. Sarah Kim-Hellmuth
Photo: Privat

Dr. Sarah Kim-Hellmuth

Dr. Sarah Kim-Hellmuth
Photo: Judith Häusler

Sarah Kim-Hellmuth

Friedmund Neumann Prize 2022

Sarah Kim-Hellmuth

Friedmund Neumann Prize 2022

In her large-scale functional genetic analyses, Dr. Sarah Kim-Hellmuth studies the genetic make-up of hundreds of people simultaneously. She then links the observed genome variation with the gene activity in different body tissues and the potential risk for certain diseases. Her work has highlighted which exact sections of the genome influence the activity of disease-associated genes when, where and how. This knowledge can now help to develop improved and personalized therapies for the treatment and prevention of a wide variety of diseases including diabetes, cardiovascular diseases, autoimmune diseases or schizophrenia.

The clinical geneticist and research group leader Dr. Sarah Kim-Hellmuth will be awarded the Friedmund Neumann Prize 2022 for her groundbreaking work in studying the genetic influence on human gene activity.

Sarah Kim-Hellmuth receives the prize in particular for her work as lead analyst in the Genotype-Tissue Expression (GTEx) consortium. She showed that the genetic regulation of gene activity is context-specific and can differ, for example, between different cell types, or between women and men. Unique to this study is the large number of different tissue types collected from hundreds of donors. This enormous dataset now enables the comparison of healthy and pathological gene activity in complex diseases. In the future, this knowledge will facilitate disease-specific research and improve drug target development.

The Schering Stiftung has awarded the 10,000-euro prize since 2011 to recognize young scientists for their outstanding basic research in human biology, organic chemistry or human medicine. The prize aims to make visible excellent scientific achievements, honor the early development of a distinctive scientific profile, and help the prize winners establish themselves in their field of science.

Sarah Kim-Hellmuth was nominated for the Friedmund Neumann Prize 2022 by Prof. Dr. Eleftheria Zeggini, director of the Institute of Translational Genomics at the Helmholtz Zentrum München. Prof. Dr. Dr. Christoph Klein, director of the Dr. von Hauner Children’s Hospital of the University of Munich (LMU), said about the prize recipient: “From a scientific and clinical perspective, Sarah Kim-Hellmuth and the GTEx consortium have contributed to a milestone that enables faster and improved discovery of disease mechanisms and paves the way toward personalized medicine.”

Read more

Side events 

Lecture to high school students: The fascinating world of genetic diversity and its influence on the human body

September 30, 2022

Oberstufenzentrum Lise Meitner – School of Science, Berlin-Neukölln (not open to the public)

Sarah Kim-Hellmuth: Scientific Lecture 

Award Ceremony 2022 

Lecture — October 04, 2022

This year's Friedmund Neumann Prize Winner, Sarah Kim-Hellmuth, will present her latest research results to a scientific audience.

Learn more
Award ceremony — September 29, 2022

The Schering Stiftung awards the Ernst Schering Prize to the biochemist and bioinformatician Gisbert Schneider. The physician and research group leader Sarah Kim-Hellmuth will be awarded with the Friedmund Neumann Prize.

Learn more


CV Sarah Kim-Hellmuth

Download File

Public Lecture

Download File

You might also be interested in

September 05, 2023

Na Cai

Friedmund Neumann Prize 2023

July 28, 2021

Judith Feucht

Friedmund Neumann Prize 2021

September 30, 2020

Florian Kahles

Friedmund Neumann Prize 2020

September 26, 2018

Alexander Bartelt

Friedmund Neumann Prize 2018

September 24, 2019

Johannes Köster

Friedmund Neumann Prize 2019


Contact & social networks

Schering Stiftung

Unter den Linden 32-34
10117 Berlin

Telefon: +49.30.20 62 29 62

Opening hours
Project space

Thursday to Monday: 1 pm - 7 pm
Saturday to Sunday: 11 am - 7 pm
free entrance

Follow us!

Follow us on our social media channels to find out the latest developments!

facebook Youtube Instagram